Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
45.90
|
44.70
|
46.70
|
44.70
|
|
|
21 078.90
|
|
|
|
44.40
|
43.70
|
47.30
|
46.50
|
|
|
27 549.50
|
|
|
|
39.50
|
39.50
|
41.70
|
41.40
|
|
|
10 708.50
|
|
|
|
39.10
|
38.80
|
39.60
|
39.60
|
|
|
|
|
|
|
40.40
|
39.90
|
40.70
|
40.30
|
|
|
1 017.50
|
|
|
|
38.10
|
38.10
|
41.30
|
40.30
|
|
|
12 416.50
|
|
|
|
37.30
|
37.30
|
38.50
|
38.40
|
|
|
962.50
|
|
|
|
36.80
|
36.80
|
37.20
|
37.00
|
|
|
|
|
|
|
38.70
|
37.50
|
38.70
|
37.50
|
|
|
63 255.00
|
|
|
|
38.50
|
38.50
|
39.60
|
39.60
|
|
|
1 188.00
|
|
Gubra is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused on the early stages of drug development and are organised in two business areas - CRO Services and Discovery & Partnerships (D&P).